ArticleCell reports2019

CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies.

William W Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.